China Isotope & Radiation Corporation

1763

CNE1000031F4

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E. Other stock markets 04:08:42 2024-06-28 EDT			5-day change	1st Jan Change
10.08 ^HKD	-2.33%		-1.37%	-24.55%

06-14	China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2023, Payable on August 13, 2024	CI
06-14	China Isotope & Radiation Corporation Approves Appointment of Chen Zan as A Non-Executive Director	CI

China Isotope & Radiation Corporation Approves Appointment of Chen Zan as A Non-Executive Director

June 14, 2024 at 09:21 am

China Isotope & Radiation Corporation announced at the AGM held on June 14, 2024, approved the appointment of Mr. Chen Zan as a non-executive Director.

Latest news about China Isotope & Radiation Corporation

China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2023, Payable on August 13, 2024	06-14	CI
China Isotope & Radiation Corporation Approves Appointment of Chen Zan as A Non-Executive Director	06-14	CI
China Isotope & Radiation Wins Bid for Gamma Irradiation Station Project	06-12	MT
China Isotope & Radiation Corporation Successfully Wins the Biding for the Project of the Gamma Irradiation Station with A Designed Capacity of 1 Million Curies of Bangladesh Institute of Nuclear Agriculture	06-11	CI
China Approves CIRC's Tomography Supporting Therapy Planning System	06-10	MT
China Isotope & Radiation, Others to Bid for Research, Office Land in China	05-27	MT
China Isotope & Radiation Corporation Announces Resignation of Xu Hongchao as General Manager	05-06	CI
China Isotope & Radiation Corporation Announces Resignation of Xu Hongchao as Executive Director, Member of the Strategy Committee, and Member of the Science and Technology Innovation Committee	05-06	CI
China Isotope & Radiation Corporation Announces First Carrier-Free Lutetium-177 GMP Production Line with Annual Production Capacity of 10,000-Curie GMP-Grade Lutetium-177	04-22	CI
China Isotope & Radiation to Form JV Company	04-04	MT
China Network Group Co., Ltd. Enters into the Investment and Cooperation Agreement with CNNC Hainan Nuclear Power	04-03	CI
China Isotope & Radiation Corporation Proposes Ordinary Final Dividend for the Year Ended 31 December 2023, Payable Before 13 August 2024	03-27	CI
China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
China Isotope & Radiation Corporation Announces Resignation of Chen Shoulei as Non-Executive Director, Vice Chairman, Members of the Strategy Committee, the Audit and Risk Management Committee and the Legal Affairs Committee of the Board	03-27	CI
China Isotope & Radiation Breath Test Kit Gets a Clinical Approval Nod	03-05	MT
China Isotope & Radiation Corporation Announces Approval by the National Medical Products Administration, Shenzhen Zhonghe Headway Bio-Sci & Tech Co. Ltd	03-04	CI
China Isotope & Radiation Arm Secures Safety License for Production Facility in Xinjiang	01-15	MT
China Isotope & Radiation Subsidiary Secures Compliance Accreditation	01-03	MT
CIRC to Buy Radiation Processing Research and Technology Firm	12-28	MT
China Isotope & Radiation Gets New Direct Controlling Shareholder	12-27	MT
China Isotope & Radiation Corporation Elects Zhang Junqi as an Executive Director	12-22	CI
China Isotope & Radiation Corporation Announces Resignation of Wang Suohui as Director	12-21	CI
China Isotope's Nuclear Energy Project Gets 'Outstanding' Rating	12-07	MT
CIRC Wins ESG Case Award in China	12-07	MT
CIRC Boosts Capital Injection in Financial Company	11-24	MT

Chart China Isotope & Radiation Corporation

Duration

Period

Chart China Isotope & Radiation Corporation

More charts

China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-29 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
CHINA ISOTOPE & RADIATION CORPORATION	-24.55%	413M
BIOMÉRIEUX	-11.78%	11.24B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-13.76%	7.29B
LANTHEUS HOLDINGS, INC.	+29.50%	5.57B
AUTOBIO DIAGNOSTICS CO., LTD.	-19.19%	3.68B
ANDON HEALTH CO., LTD.	+7.62%	2.58B
10X GENOMICS, INC.	-65.24%	2.33B
VITROLIFE AB	-10.48%	2.23B
MYRIAD GENETICS, INC.	+27.80%	2.21B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-19.12%	1.57B

Diagnostic & Testing Substances